A Morning Prayer

Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patientsMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal

UPDATED: Sanofi Genzyme Applies to FDA for Approval of Alemtuzumab to Treat Relapsing MS/About-the-Society/News/UPDATED-Genzyme-Applies-to-FDA-for-Approval-of-Ale … read morePosted At: National MS Society

Spontaneous regression of tumor-stage cutaneous T-cell lymphoma in a multiple sclerosis patient after discontinuing fingolimodMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal

What to know about marijuana and multiple sclerosisMarijuana has many potential uses, which includes the treatment of specific symptoms of multiple sclerosis (MS). Learn more about the possible benefits of marijuana for people with...

Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?Multiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal